Juno Pharmaceuticals Corp.

Omega Plastics Group, an integrated plastic injection moulding group has announced the addition of new injection moulding press capacity at both Signal Plastics and Omega Plastics. Signal Plastics, based in Washington, has recently acquired a state-of-the-art Yizumi 700-tonne injection moulding press. This strategic acquisition aims to bolster production capabilities and meet the increasing demand from an existing customer as part of their production ramp-up. Equipped with a Sepro robot for demoulding and a conveyor belt to enhance productivity, the new 700-tonne press will significantly contribute to meeting customer requirements efficiently and effectively. In addition to the press expansion, Omega Plastics based in Gateshead, has established a dedicated tool trial cell to support its UK toolroom and in-house tool manufacture, operating independently of planned production activities. This specialised validation facility enables Omega Plastics to test and validate new tools without any impact on ongoing production processes. The trial cell is equipped with two injection moulding machines, including a 40-tonne machine and a 100-tonne machine. This dedicated resource ensures optimal flexibility and precision during tooling validation processes, enhancing the overall customer experience. The trial cell offers a dedicated area for comprehensive testing, allowing for analysis of key characteristics such as fill patterns, thermal imaging, gate freeze studies, cycle time efficiencies, and their direct influence on final product quality. By introducing this dedicated trial resource, Omega Plastics can support customers by providing insights and expert validation of tooling solutions. These recent investments in additional injection moulding capacity and dedicated tooling resources are part of Omega Plastics Group's ongoing commitment to continuous improvement and customer satisfaction. Over the past five years, the group has added seven additional injection moulding machines, significantly expanding its injection moulding machine capacity from 23 to 30 machines, ranging from 40T to 1,300T. Further significant investments have been made in warehousing, and material handling systems to support the additional moulding capacity. Across the wide press range, Omega Plastics Group can produce components with shot weights ranging from less than 1g to 4kg. The group has capability to mould complex technical hand loads and overmoulds through to fully automated robot demoulding with integrated conveyor systems. During that time investments have also been made in the toolroom, including the acquisition of a Puma GT 2100 CNC Lathe, a new surface grinder, an Agie Carmilles EDM drill and a Fanuc ROBOCUT wire EDM, as well as in metrology software and capabilities. These investments allows Omega Plastics to aim to consistently meet customer demands and provide cutting-edge tooling solutions. Peter Sayer, group commercial director at Omega Plastics Group, said: "At Omega Plastics Group, our mission is to provide high-quality plastic injection mould tooling, components, assembly, and technical solutions on time and with exceptional customer service. These recent expansions and investments in our capabilities and resources demonstrate our commitment to our customers, ensuring we continue to exceed their expectations and deliver innovative solutions."

Omega Plastics Group, an integrated plastic injection moulding group, has achieved ISO 14001 certification. ISO 14001 is an international standard that sets out the requirements for an environmental management system (EMS). The certification is a process that requires companies to demonstrate their commitment to environmental management. It includes an assessment of a company’s EMS practices, policies, and procedures. During the process, Omega Plastics Group was able to demonstrate its focus on reducing waste and emissions, conserving natural resources, and promoting sustainable practices. This included the use of recycled materials, investing in energy-efficient manufacturing equipment and LED lighting, monitoring, and reducing energy usage, taking steps to reduce water usage, and managing waste responsibly. “We are delighted to achieve ISO 14001 certification” said Craig Swinhoe, chief executive officer at Omega Plastics Group. “A key part of our vision is to be a sustainable manufacturer. Obtaining ISO 14001 demonstrates the importance to us of environmental sustainability. We are committed to reducing our environmental impact, waste and costs and helping our customers do the same. I am proud of our team’s ongoing efforts to make a positive impact on the environment.” Julian Jamieson, group operations director, further explained “ISO 14001 reduces our environmental impact by helping us to identify and manage our environmental risks and opportunities. It allows us to improve our environmental performance by setting measurable environmental objectives and targets, and by monitoring and reporting on their progress. “ISO 14001 and the systematic approach to environmental management will help us to comply with environmental regulations. It also means that we are well positioned to meet the changing environmental needs of our customers.”

Most drug addicts find it difficult to wean themselves away from the fatal substance and require a protracted therapy for that. And the pace with which the substance abuse problem has become increased, means that such therapies are gaining traction. An important part of it is the drug screening process which has seen its market grow steadily owing to the increasing number of drug addicts around the world. Going forward, the drug screening market is expected to rise further because of the formulation of strict rules and regulations to curb the menace. Those mostly include mandatory drug and alcohol testing. Increased government spending on such devices is serving to benefit the market. Another factor that is stoking the drug screening market is the swift approval and launch of more sophisticated products owing to the constant thrust on product development by keen players. However, on the flipside, ban of consumption of alcohol in many Islamic nations, prohibition of workplace drug testing in many organizations, and inaccuracy of breathalyzers at times is posing a challenge to growth in market. Going forward, oral fluid testing will open up new frontiers of growth for players in the market. Yet another channel of growth would open up because of fingerprint-based drug screening. Currently, North America and Europe account for maximum share in the drug screening market. This is because of organizations such as Drug Enforcement Administration (DEA) in place in the U.S. and various stringent regulations in North American and European countries. In the next few years, however, emerging economies of Asia Pacific will power market growth because of the mushrooming small and medium drug treatment institutions in the region. Most of the savvy players are turning their gaze towards the region in order to grow further. Global Drug Screening Market: Overview Drugs are the number one cause of premature death across the world and despite tight security measures at the borders, a number of governments are failing to contain this expanding issue. Now, several governments are adopting screen methods to test potential addicts on the run time as well as encouraging corporate organizations to introduce workplace check-ups. Consequently, the demand in the global drug screening market is poised to expand a notable CAGR during the forecast period of 2017 to 2025. This report on the global drug screening market is an all-inclusive business intelligence study that showcases its lucrativeness. Compiled by a group of professional research analysts, the report aims to aid as a reliable guide for targeted audiences such as drug and alcohol testing laboratories, manufacturers of testing product and equipment, rapid drug screen device manufacturers, healthcare providers, law enforcement agencies, government agencies, and venture capitalists. Starting with an executive summary that includes overview of how the demand for drug screening has evolved in the recent past and where it is headed, the report dives into the analysis of various market dynamics, such as trends, drivers, opportunities, and challenges. The report also divides the drug screening market into logical segments and determines the potential of demand that can be expected out of various regions and countries. Finishing up a thorough study, the report includes an extended and featured section on the competitive landscape of the global drug screening market, wherein a number of key vendors have been profiled for their product portfolio, business establishment, and recent strategic decisions. GET BROCHURE OF THE REPORT Global Drug Screening Market: Trends and Opportunities Some of the key factors driving the demand in the global drug screening market are: enforcement of stringent laws that mandate drug and alcohol testing in a number of countries, and growing consumption of drug and alcohol and inflicted community issues, presence of government funding in major markets. In addition to that, a number of new products, devices, and services have gained regulatory approvals, and are gaining adoption among both government agencies and corporate organizations. On the other hand, ban on alcohol consumption in a number of countries that follow Islam ideologies, prohibition of workplace drug testing in some countries, and issues pertaining to accuracy and specificity of breathalyzer are a few restraints obstructing the drug screen market from flourishing. Global Drug Screening Market: Market Potential The vendors operating in this market are expected to gain new opportunities is they transform their business strategies towards oral fluid testing and develop the concept of fingerprint-based drug screening. Additionally, market players are expected to make a foray into the emerging economies to find new consumers. GET TABLE OF CONTENT OF THE REPORT Global Drug Screening Market: Regional Analysis North America and Europe are the two most profitable regions in the global drug screening market. In the developed country of the U.S., government has its Drug Enforcement Administration (DEA) in place since long that readily adopts new products that helps them curtail the ubiquity of drugs. Similar controlling measures are taken in a number of European countries such as the U.K., Germany, and France. However, the emerging economies in Asia Pacific, wherein small and medium enterprises are mushrooming, are expected to turn the region into a lucrative one towards the end of the forecast period. Global Drug Screening Market: Competitive Landscape Siemens Healthineers, Drägerwerk, Alere, Alfa Scientific Designs, Thermo Fisher, Roche, Shimadzu, MPD, Inc., OraSure, Lifeloc, LabCorp, Psychemedics, Quest Diagnostics, Omega Laboratories, SureHire, CRL, and CannAmm are a few key players currently ahead of the curve in the global drug screen market. GET DISCOUNT ON THE LATEST REPORT TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others. 5-Point Growth Formula The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs. The 5-point growth formula includes the following points: Current and Future Threats Accurate Trend Analysis Regional Assessment Industrial Analogy COVID-19 Impact Current and Future Threats Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats. Accurate Trend Analysis Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues. Regional Assessment Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market. Industrial Analogy The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation. COVID-19 Impact The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly. The reports offer answers to the top 7 questions that revolve around the growth of the market What are the diverse growth parameters influencing the market? Which regions will contribute largely to the growth of the market What are the recent innovations and technological advancements in the market? What are the emerging trends across the market? How has COVID-19 affected the market? What will be the post-pandemic scenario of the market? What are the major threats that will dent the growth prospects of the market? About TMR Research TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends. Contact: Rohit Bhisey TMR Research, 3739 Balboa St # 1097, San Francisco, CA 94121 United States Tel: +1-415-520-1050 Visit Site: